AI Generated Content

This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.

A ray of hope: Tokyo’s Nipah virus vaccine set for human trials in April

SUMMARY

AI Generated Content
  • Nipah vaccine enters early human trials in April.
  • Tokyo Uni's vaccine uses a measles virus vector.
  • Oxford Uni also has a Nipah vaccine in Phase 2 trials.
AD
Other Interesting Stories
AD